FDA bans references to sinusitis on OTC nasal decongestants

10/12/2005 | Wall Street Journal, The

The FDA said OTC nasal decongestants no longer will be allowed to cite "sinusitis" on their products after determining there is no evidence the drugs are effective as a substitute for antibiotics, the normal treatment for a bacterial infection. In addition to drugs for colds and allergies, new regulations also are to apply to topical decongestants and nasal sprays, as well as to combination products and to generic versions of those drugs.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY